CYCC: Summary for Cyclacel Pharmaceuticals, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 7:55am EST - Canadian Markets open in 1 hour and 35 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Cyclacel Pharmaceuticals, Inc. (CYCC)

On Feb 9: 2.04 USD 0.00 (0.00%)

MORE ON CYCC

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Cyclacel Pharmaceuticals, Inc. (NGM:CYCC) Delayed quote data

Last Trade:	2.04 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	2.04
Open:	N/A
Bid:	2.09 x 100
Ask:	2.12 x 2100
1y Target Est:	7.00

Day's Range:	N/A - N/A
52wk Range:	0.26 - 4.08
Volume:	0
Avg Vol (3m):	5,555,010
Market Cap:	49.84M
P/E (ttm):	N/A
EPS (ttm):	-1.10
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add CYCC to Portfolio

Download Data

HEADLINES

•	Hardinge, Cyclacel: Early Volume Plays
	at TheStreet.com (Thu, Feb 4)

•	Coverage initiated on Cyclacel Pharma by Roth Capital
	Briefing.com (Thu, Feb 4)

•	A Miracle Indicator & 5 Stocks Ready To Rock
	TradingMarkets.com (Thu, Jan 28)

•	CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
	EDGAR Online (Wed, Jan 27)

•	Cyclacel Rises (Again!) on False NEJM Rumor: BioBuzz
	at TheStreet.com (Tue, Jan 26)

•	CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
	EDGAR Online (Mon, Jan 25)

•	Biotech Stock Mailbag: GenVec
	at TheStreet.com (Fri, Jan 22)

•	CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements a
	EDGAR Online (Thu, Jan 21)

•	Rumor of Cyclacel Journal Article False: BioBuzz
	at TheStreet.com (Wed, Jan 20)

•	Dearborn, Cyclacel: Midday Volume Plays
	at TheStreet.com (Wed, Jan 20)

More Headlines for CYCC...

ANALYST

EPS Est (next year) (Dec-09) :	-0.87
EPS Est (in 2 years) (Dec-10) :	-0.70
Avg Rec (current)*:	1.7
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders.

Full Company Profile

Add to Portfolio

Email to a Friend

•